Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes

(Medage today) – Chicago – The addition of Cagrilinetide survey to a GLP -1 receptor agonist increased weight loss in adults with obesity with or without diabetes type 2, a pair of phase IIIa trials found. In Redefinine 1, which included 3,417 …